ATE239498T1 - Entzündungshemmende zusammensetzung - Google Patents

Entzündungshemmende zusammensetzung

Info

Publication number
ATE239498T1
ATE239498T1 AT99401720T AT99401720T ATE239498T1 AT E239498 T1 ATE239498 T1 AT E239498T1 AT 99401720 T AT99401720 T AT 99401720T AT 99401720 T AT99401720 T AT 99401720T AT E239498 T1 ATE239498 T1 AT E239498T1
Authority
AT
Austria
Prior art keywords
composition
alpha
inflammatory composition
treatment
msh
Prior art date
Application number
AT99401720T
Other languages
English (en)
Inventor
Yann Mahe
Nelly Billoni
Lionel Breton
Lien Bui-Bertrand
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9528645&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE239498(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE239498T1 publication Critical patent/ATE239498T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99401720T 1998-07-15 1999-07-08 Entzündungshemmende zusammensetzung ATE239498T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809055A FR2781157B1 (fr) 1998-07-15 1998-07-15 Composition anti-inflammatoire

Publications (1)

Publication Number Publication Date
ATE239498T1 true ATE239498T1 (de) 2003-05-15

Family

ID=9528645

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99401720T ATE239498T1 (de) 1998-07-15 1999-07-08 Entzündungshemmende zusammensetzung

Country Status (7)

Country Link
US (1) US6337315B1 (de)
EP (1) EP0972522B2 (de)
JP (1) JP3746169B2 (de)
AT (1) ATE239498T1 (de)
DE (1) DE69907577T3 (de)
ES (1) ES2199534T5 (de)
FR (1) FR2781157B1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
US6887846B2 (en) 1999-03-24 2005-05-03 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
US6803044B1 (en) 1999-03-24 2004-10-12 Zengen, Inc. Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6800291B1 (en) 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
FR2806906A1 (fr) * 2000-04-04 2001-10-05 C F E B Sisley Composition cosmetique comprenant un extrait d'algue brune agissant sur la quantite de gag
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
US6780838B2 (en) 2001-01-29 2004-08-24 Zengen, Inc. Compounds for treating fungal pathologies of the oral cavity
DE60234164D1 (de) * 2001-03-19 2009-12-10 Senju Pharma Co Neues a-liponsäurederivat und dessen verwendung
US6894028B2 (en) * 2001-04-06 2005-05-17 Zengen, Inc. Use of KPV tripeptide for dermatological disorders
FR2826577B1 (fr) * 2001-06-29 2003-10-03 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour ameliorer la fonction barriere de la peau
US7115574B2 (en) 2001-12-10 2006-10-03 Zengen, Inc. System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en) 2001-12-17 2005-09-06 Zengen, Inc. Use of a polypeptide for treatment of pruritis in animals
FR2835528B1 (fr) * 2002-02-01 2004-03-12 Inst Europ Biolog Cellulaire Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
FR2857581B1 (fr) * 2003-07-18 2007-11-30 Inst Europ Biolog Cellulaire Association utile dans le traitement preventif et curatif de l'alopecie d'un agent anti-inflammatoire et d'un filtre uvb
FR2870242B1 (fr) 2004-05-11 2010-08-20 Inst Europeen Biologie Cellulaire Peptides ou conjugues peptidiques derives de la msh et leur utilisation dans le traitement cosmetique de la canitie.
FR2870243B1 (fr) 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
FR2870244B1 (fr) 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
EP1755651B1 (de) 2004-06-14 2016-10-12 BASF Beauty Care Solutions S.A.S. Kosmetische zubereitungen enthaltend pth-fragmente
US20100279944A1 (en) * 2006-03-30 2010-11-04 Ronald Mathison Suppression and treatment of neuropathic pain
FR2900573B1 (fr) * 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
DE102009055970B4 (de) * 2009-11-27 2014-04-17 Marcus Asam Kosmetische Wirkstoffzubereitung
WO2013075116A2 (en) 2011-11-17 2013-05-23 Heliae Development, Llc Omega 7 rich compositions and methods of isolating omega 7 fatty acids
CN107530272B (zh) * 2015-04-08 2021-10-22 帝斯曼知识产权资产管理有限公司 共混物
US10149811B2 (en) * 2016-02-11 2018-12-11 Elc Management Llc Methods and compositions for stimulating collagen synthesis in skin cells
KR102631159B1 (ko) * 2016-10-21 2024-01-30 가부시키가이샤 시세이도 라미닌 511 생성 촉진제, 표피 기저막 안정화제 및/또는 표피 줄기 세포 감소 억제 또는 증가 촉진제의 스크리닝 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157023A (en) * 1984-08-21 1992-10-20 Lipton James M Antipyretic and anti-inflammatory lys pro val compositions and method of use
US5028592A (en) * 1986-08-08 1991-07-02 Lipton James M Antipyretic and anti-inflammatory peptides
CN1045589C (zh) * 1992-12-09 1999-10-13 协和发酵工业株式会社 N-酰基谷氨酰胺衍生物
WO1994024984A2 (en) * 1993-04-30 1994-11-10 Winget Rodner R Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2753628B1 (fr) * 1996-09-26 1998-11-20 Produit destine a prevenir et a soigner les maladies de la peau, procede d'elaboration et utilisation dudit produit
DE19653736C2 (de) † 1996-12-12 2002-11-21 Lancaster Group Gmbh Kosmetisches Präparat mit Peptidzusatz

Also Published As

Publication number Publication date
JP3746169B2 (ja) 2006-02-15
EP0972522B1 (de) 2003-05-07
DE69907577T3 (de) 2008-03-06
ES2199534T5 (es) 2008-04-16
FR2781157B1 (fr) 2000-08-25
DE69907577T2 (de) 2004-04-08
EP0972522A1 (de) 2000-01-19
US6337315B1 (en) 2002-01-08
EP0972522B2 (de) 2007-10-31
DE69907577D1 (de) 2003-06-12
JP2000080024A (ja) 2000-03-21
ES2199534T3 (es) 2004-02-16
FR2781157A1 (fr) 2000-01-21

Similar Documents

Publication Publication Date Title
DE69907577D1 (de) Entzündungshemmende Zusammensetzung
CA2279967A1 (en) Method of enhancing hair growth
AU5857498A (en) Cosmetic preparations containing extracts from phyllantus emblica and centella asiatica and/or bacopa monnieri
FI973468L (fi) Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
BR0115990A (pt) Preparações cosméticas e/ou dermofarmacêutica contendo proteìnas nativas da planta argania spinosa
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
BR9811755A (pt) Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
EA200501069A1 (ru) Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
EP0821969A3 (de) Arzneimittelzusammensetzung enthaltend TCF-II
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
MXPA01006011A (es) Composicion para tratamiento de quemaduras.
ES2088682T3 (es) Agente bronceador de la piel.
MX9307320A (es) Proteina substancialmente pura para la inhibicion de la melanogenesis en celulas pigmentarias, metodo para su produccion y metodo para el control de la melanogenesis en celulas pigmentarias.
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung
RU96109746A (ru) Способ введения настоя цветков календулы лекарственной
RU96100994A (ru) Лечебно-косметическое средство
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
IT8719948A0 (it) Composizioni cosmetiche topiche per il trattamento stimolante la crescita dei capelli.
CA2255521A1 (en) Compositions for treatment of burns
IT1290905B1 (it) Formulazione per il trattamento cosmetico e/o terapeutico dell'acne e metodo per la sua preparazione.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0972522

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0972522

Country of ref document: EP

REN Ceased due to non-payment of the annual fee